Interleukin-17 modulates myoblast cell migration by inhibiting urokinase type plasminogen activator expression through p38 mitogen-activated protein kinase

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 2, 2013, Pages 464-475

  Kocić, Jelena ^a   Santibañez, Juan F ^a   Krstić, Aleksandra ^a   Mojsilović, Slavko ^a   Ilić, Vesna ^a   Bugarski, Diana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Differentiation; IL 17; Migration; Myoblast; p38; uPA

Indexed keywords

INTERLEUKIN 17; MITOGEN ACTIVATED PROTEIN KINASE P38; UROKINASE;

ARTICLE; CELL CULTURE; CELL MIGRATION; ENZYME INHIBITION; IN VITRO STUDY; MUSCLE DEVELOPMENT; MYOBLAST; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SKELETAL MUSCLE;

ACTIN CYTOSKELETON; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; IMIDAZOLES; INTERLEUKIN-17; MAP KINASE SIGNALING SYSTEM; MICE; MYOBLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; TRANSCRIPTIONAL ACTIVATION; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84872290003     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2012.11.010     Document Type: Article

References (45)

1. H. Abramovici, and S.H. Ge Morphological changes and spatial regulation of diacylglycerol kinase-zeta, syntrophins, and Rac1 during myoblast fusion Cell Motility and the Cytoskeleton 64 7 2007 549 567
2. L. Becciolini, E. Meacci, C. Donati, F. Cencetti, E. Rapizzi, and P. Bruni Sphingosine 1-phosphate inhibits cell migration in C2C12 myoblasts Biochimica et Biophysica Acta 1761 1 2006 43 51
3. B.A. Bondesen, K.A. Jones, W.C. Glasgow, and G.K. Pavlath Inhibition of myoblast migration by prostacyclin is associated with enhanced cell fusion FASEB Journal 21 12 2007 3338 3345
4. S.C. Bryer, and T.J. Koh The urokinase-type plasminogen activator receptor is not required for skeletal muscle inflammation or regeneration American Journal of Physiology: Regulatory Integrative and Comparative Physiology 293 3 2007 1152 1158
5. E. Carmeli, M. Moas, A.Z. Reznick, and R. Coleman Matrix metalloproteinases and skeletal muscle: a brief review Muscle and Nerve 29 2 2004 191 197
6. G. Chevrel, G. Page, C. Granet, N. Streichenberger, A. Varennes, and P. Miossec Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis Journal of Neuroimmunology 137 1-2 2003 125 133
7. A. Cuadrado, and A.R. Nebreda Mechanisms and functions of p38 MAPK signalling Biochemical Journal 429 3 2010 403 417
8. W.C. Duivenvoorden, H.W. Hirte, and G. Singh Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells Invasion and Metastasis 17 1997 312 322
9. E. El Fahime, P. Mill, J.F. Lafreniere, Y. Torrente, and J.P. Tremblay The urokinase plasminogen activator: an interesting way to improve myoblast migration following their transplantation Experimental Cell Research 280 2 2002 169 178
10. D. Figarella-Branger, M. Civatte, C. Bartoli, and J.F. Pellissier Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies Muscle and Nerve 28 2003 659 682
11. S.L. Gaffen Recent advances in the IL-17 cytokine family Current Opinion in Immunology 23 5 2011 613 619
12. S.L. Gaffen Structure and signaling in the IL-17 receptor family Nature Reviews Immunology 9 8 2009 556 567
13. A. Hall Rho GTPases and the control of cell behaviour Biochemical Society Transactions 33 2005 891 895
14. H. Huang, H.J. Kim, E.J. Chang, Z.H. Lee, S.J. Hwang, and H.M. Kim IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling Cell Death and Differentiation 16 10 2009 1332 1343
15. W. Huang, V. La Russa, A. Alzoubi, and P. Schwarzenberger Interleukin-17A: a T-cell-derived growth factor for murine and human mesenchymal stem cells Stem Cells 24 6 2006 1512 1518
16. S. Ivanov, and A. Linden Interleukin-17 as a drug target in human disease Trends in Pharmacological Sciences 30 2 2009 95 103
17. Y. Iwakura, H. Ishigame, S. Saijo, and S. Nakae Functional specialization of interleukin-17 family members Immunity 34 2 2011 149 162
18. G. Jovcić, D. Bugarski, A. Krstić, M. Vlaski, M. Petakov, and S. Mojsilović The effect of interleukin-17 on hematopoietic cells and cytokine release in mouse spleen Physiological Research 56 3 2007 331 339
19. I. Kiian, N. Tkachuk, H. Haller, and I. Dumler Urokinase-induced migration of human vascular smooth muscle cells requires coupling of the small GTPases RhoA and Rac1 to the Tyk2/PI3-K signalling pathway Thrombosis and Haemostasis 89 5 2003 904 914
20. J. Kocić, J.F. Santibañez, A. Krstić, S. Mojsilović, I.O. Dordević, and D. Trivanović Interleukin 17 inhibits myogenic and promotes osteogenic differentiation of C2C12 myoblasts by activating ERK1,2 Biochimica et Biophysica Acta 1823 4 2012 838 849
21. J. Kocić, D. Bugarski, and J.F. Santibanez SMAD3 is essential for transforming growth factor-β1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes European Journal of Cancer 48 10 2012 1550 1557
22. T.J. Koh, S.C. Bryer, A.M. Pucci, and T.H. Sisson Mice deficient in plasminogen activator inhibitor-1 have improved skeletal muscle regeneration American Journal of Physiology: Cell Physiology 289 1 2005 217 223
23. M. Kondo, Y. Murakawa, N. Harashima, S. Kobayashi, S. Yamaguchi, and M. Harada Roles of proinflammatory cytokines and the Fas/Fas ligand interaction in the pathogenesis of inflammatory myopathies Immunology 128 2009 589 599
24. C. Le Clainche, and M.F. Carlier Regulation of actin assembly associated with protrusion and adhesion in cell migration Physiological Reviews 88 2 2008 489 513
25. M.P. Lewis, H.L. Tippett, A.C. Sinanan, M.J. Morgan, and N.P. Hun Gelatinase-B (matrix metalloproteinase-9; MMP-9) secretion is involved in the migratory phase of human and murine muscle cell cultures Journal of Muscle Research and Cell Motility 21 3 2000 223 233
26. F.J. Lluís, M. Suelves, M. Parra, G. Aniorte, E. Gallardo, and I. Illa Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo Blood 97 6 2001 1703 1711
27. G. Lluri, and D.M. Jaworski Regulation of TIMP-2, MT1-MMP, and MMP-2 expression during C2C12 differentiation Muscle and Nerve 32 4 2005 492 499
28. J. Morgan Muscle satellite cells International Journal of Biochemistry and Cell Biology 35 2003 1151 1156
29. P. Munoz-Canoves, F. Miralles, M. Baiget, and J. Félez Inhibition of urokinase-type plasminogen activator (uPA) abrogates myogenesis in vitro Thrombosis and Haemostasis 77 3 1997 526 534
30. A. Philippou, M. Maridaki, and M. Koutsilieris The role of urokinase-type plasminogen activator (uPA) and transforming growth factor beta 1 (TGFbeta1) in muscle regeneration In Vivo 22 6 2008 735 750
31. A.J. Ridley, M.A. Schwartz, K. Burridge, R.A. Firtel, M.H. Ginsberg, and G. Borisy Cell migration: integrating signals from front to back Science 302 5651 2003 1704 1709
32. D. Sancho, M. Vicente-Manzanares, M. Mittelbrunn, M.C. Montoya, M. Gordón-Alonso, and J.M. Serrador Regulation of microtubule-organizing center orientation and actomyosin cytoskeleton rearrangement during immune interactions Immunological Reviews 189 2002 84 97
33. J.F. Santibáñez, J. Guerrero, M. Quintanilla, A. Fabra, and J. Martínez Transforming growth factor-beta1 modulates matrix metalloproteinase-9 production through the Ras/MAPK signaling pathway in transformed keratinocytes Biochemical and Biophysical Research Communications 296 2 2002 267 273
34. P. Schwarzenberger, W. Huang, P. Ye, P. Oliver, M. Manuel, and Z. Zhang Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis Journal of Immunology 164 2000 4783 4789
35. J.H. Shin, D.W. Shin, and M. Noh Interleukin-17A inhibits adipocyte differentiation in human mesenchymal stem cells and regulates pro-inflammatory responses in adipocytes Biochemical Pharmacology 77 12 2009 1835 1844
36. T.H. Sisson, M.H. Nguyen, B. Yu, M.L. Novak, R.H. Simon, and T.J. Koh Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration Blood 114 24 2009 5052 5061
37. M. Suelves, B. Vidal, A.L. Serrano, M. Tjwa, J. Roma, and R. López-Alemany uPA deficiency exacerbates muscular dystrophy in MDX mice Journal of Cell Biology 178 6 2007 1039 1051
38. Z. Sun, Y.H. Chen, P. Wang, J. Zhang, V. Gurewich, and P. Zhang The blockage of the high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation Biochimica et Biophysica Acta 1596 2 2002 182 192
39. P. Szodoray, P. Alex, N. Knowlton, M. Centola, I. Dozmorov, and I. Csipo Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family membersB-cell activating factor and a proliferation inducing ligand Rheumatology 49 10 2010 1867 1877
40. A. Tournadre, and P. Miossec Interleukin-17 in inflammatory myopathies Current Rheumatology Reports 14 3 2012 252 256
41. V. Villar, J. Kocić, D. Bugarski, G. Jovcic, and J.F. Santibanez SKIP is required for TGF-β1-induced epithelial mesenchymal transition and migration in transformed keratinocytes FEBS Letters 584 22 2010 4586 4592
42. J.M. Wells, and S. Strickland Regulated localization confers multiple functions on the protease urokinase plasminogen activator Journal of Cellular Physiology 171 1997 217 225
43. S. Xu, and X. Cao Interleukin-17 and its expanding biological functions Cellular and Molecular Immunology 7 2010 164 174
44. D. Yaffe, and O. Saxel Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle Nature 270 5639 1977 725 727
45. S. Zuluaga, A. Gutiérrez-Uzquiza, P. Bragado, A. Alvarez-Barrientos, M. Benito, and A.R. Nebreda p38alpha MAPK can positively or negatively regulate Rac-1 activity depending on the presence of serum FEBS Letters 581 20 2007 3819 3825